JUNE 8, 2018

Cimzia Receives New Indication for Moderate to Severe Plaque Psoriasis

The FDA approved a new indication for certolizumab pegol (Cimzia, UCB) to treat moderate to severe plaque psoriasis in adults.

To read the full story, Log in or Sign up for a Free Account

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select